lovastatin has been researched along with Insulin Resistance in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Antonello, M; Brosolo, G; Catena, C; Da Porto, A; Donnini, D; Romanin, A; Sechi, LA; Soardo, G; Toritto, P; Vanin, F; Varisco, E | 1 |
| Battista, F; Bonaduce, D; Bosso, G; Brambilla, N; D'Amato, M; Fazio, V; Galletti, F; Gentile, M; Giacovelli, G; Mercurio, V; Pucci, G; Schillaci, G; Vitalini, C | 1 |
| Hsu, WH; Hsu, YW; Lee, BH; Lu, SS; Pan, TM | 1 |
| Elfakhani, M; Hussein, D; Mills, N; Mo, H; Torabi, S; Verbeck, GF | 1 |
| Esposito, G; Izzo, R; Manzi, MV; Rozza, F; Santoro, M; Schiattarella, GG; Serino, F; Stabile, E; Trimarco, B; Trimarco, V | 1 |
| Cappelli, V; De Leo, V; Di Sabatino, A; Massaro, MG; Morgante, G | 1 |
| Carlomagno, G; Fazio, S; Mercurio, V; Pirozzi, C; Ruvolo, A | 1 |
| McCarty, MF | 1 |
| Cintra, DE; Lalli, CA; Pauli, JR; Prada, PO; Ropelle, ER; Saad, MJ; Velloso, LA | 1 |
| Chang, CL; Ho, LT; Hwu, CM; Kwok, CF; Shih, KC | 1 |
| Grundy, SM; Vega, GL | 1 |
| Chen, X; Hu, P; Huang, D; Huang, M; Xie, M; Yu, Y; Zhang, H | 1 |
| Chamberlain, LH | 1 |
1 review(s) available for lovastatin and Insulin Resistance
| Article | Year |
|---|---|
Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.
Topics: Apolipoproteins B; Cholesterol, LDL; Cholesterol, VLDL; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Lovastatin; Male; Niacin | 1998 |
5 trial(s) available for lovastatin and Insulin Resistance
| Article | Year |
|---|---|
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
Topics: Adult; Aged; Berberine; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Fatty Alcohols; Female; Humans; Hypertrophy, Left Ventricular; Insulin Resistance; Lipid Metabolism; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Placebos; Treatment Outcome | 2019 |
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial.
Topics: Aged; Berberine; Biomarkers; Blood Glucose; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Dyslipidemias; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Insulin; Insulin Resistance; Italy; Lipids; Lovastatin; Male; Middle Aged; Morus; Plant Extracts; Plant Leaves; Time Factors; Treatment Outcome; Vasodilation | 2015 |
Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Topics: Adult; Antioxidants; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyslipidemias; Female; Hirsutism; Humans; Hyperandrogenism; Inositol; Insulin Resistance; Lovastatin; Polycystic Ovary Syndrome; Thioctic Acid; Young Adult | 2015 |
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome.
Topics: Anticholesteremic Agents; Berberine; Cardiotonic Agents; Dietary Supplements; Fatty Alcohols; Female; Humans; Insulin Resistance; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Vasodilation; Ventricular Remodeling | 2012 |
Lovastatin lowers serum cholesterol levels in non-insulin-dependent diabetes mellitus patients without altering their insulin sensitivity.
Topics: Aged; Anticholesteremic Agents; Cholesterol; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Lovastatin; Male; Middle Aged | 1996 |
7 other study(ies) available for lovastatin and Insulin Resistance
| Article | Year |
|---|---|
Effects of Monacolin K in Nondiabetic Patients with NAFLD: A Pilot Study.
Topics: Glutathione Disulfide; Humans; Insulin Resistance; Liver; Lovastatin; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Pilot Projects; Prospective Studies | 2023 |
Monacolin K and monascin attenuated pancreas impairment and hyperglycemia induced by advanced glycation endproducts in BALB/c mice.
Topics: Animals; Diabetes Mellitus; Female; Fermentation; Glucose Tolerance Test; Glycation End Products, Advanced; Heterocyclic Compounds, 3-Ring; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Lovastatin; Male; Mice; Mice, Inbred BALB C; Monascus; Oryza; Pancreas | 2013 |
Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes.
Topics: 3T3 Cells; Adipocytes; Adipogenesis; Adiponectin; Animals; CCAAT-Enhancer-Binding Proteins; Cell Survival; Down-Regulation; Fatty Acid-Binding Proteins; Gene Expression; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Leptin; Lovastatin; Mevalonic Acid; Mice; PPAR gamma; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2014 |
Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen.
Topics: Animals; Cholesterol, LDL; Clinical Trials as Topic; Cohort Studies; Diet, Vegetarian; Dietary Fats; Dietary Supplements; Double-Blind Method; Drug Costs; Enzyme Activation; Fatty Alcohols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Lovastatin; Myocardial Infarction; Platelet Activation; Protein Prenylation; Protein Processing, Post-Translational; Rabbits; Rats; rho GTP-Binding Proteins; Safety | 2002 |
Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet.
Topics: Animals; Blood Glucose; Body Weight; Dietary Fats; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Liver; Lovastatin; Male; Muscle, Skeletal; Rats; Rats, Wistar; Signal Transduction | 2008 |
[Effects of lovastatin on plasma lipid, plasma glucose and insulin metabolism of patients with type II B hyperlipemia].
Topics: Aged; Anticholesteremic Agents; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Insulin; Insulin Resistance; Lovastatin; Male; Middle Aged | 1999 |
Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Aminopeptidases; Animals; Anticholesteremic Agents; Caveolin 2; Caveolins; Cells, Cultured; Cholesterol; Cystinyl Aminopeptidase; Glucose Transporter Type 1; Glucose Transporter Type 4; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Lovastatin; Mevalonic Acid; Mice; Monosaccharide Transport Proteins; Muscle Proteins | 2001 |